Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning (Q44612723)

4 December 2017

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning (English)

1 reference

transplantation conditioning

4 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550810

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

20 March 2024

2

Michael Boeckh

1 reference

4 December 2017

9

Rainer Storb

1 reference

4 December 2017

7

Brenda Sandmaier

1 reference

4 December 2017

3

Barry Storer

1 reference

4 December 2017

8

David Maloney

1 reference

4 December 2017

10

Jan Storek

1 reference

4 December 2017

5

Kristen White

1 reference

4 December 2017

Michael Maris

1

1 reference

4 December 2017

Monja Dawson

4

1 reference

4 December 2017

Michael Keng

6

1 reference

4 December 2017

Barry Storer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550810

20 March 2024

Brenda Sandmaier

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550810

20 March 2024

David Maloney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550810

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550810

20 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

http://www.exphem.org/article/S0301472X03002017/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550810

https://api.elsevier.com/content/article/PII:S0301472X03002017?httpAccept=text/xml

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

https://api.elsevier.com/content/article/PII:S0301472X03002017?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

20 March 2024

published in

Experimental Hematology

1 reference

4 December 2017

31

1 reference

4 December 2017

10

1 reference

4 December 2017

941-952

1 reference

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

High rate of secondary viral and bacterial infections in patients undergoing allogeneic bone marrow mini-transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Cell-Mediated Immunity to Varicella-Zoster Virus after Allogeneic Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Infection with Herpes Simplex Virus and Cell-Mediated Immunity after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Cytomegalovirus Infection and Specific Cell-Mediated Immunity after Marrow Transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Enumeration of viral antigen-reactive helper T lymphocytes in human peripheral blood by limiting dilution for analysis of viral antigen-reactive T-cell pools in virus-seropositive and virus-seronegative individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Common lymphoid progenitors rapidly engraft and protect against lethal murine cytomegalovirus infection after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Infectious and immunosuppressive complications of purine analog therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900201-7

7 January 2021

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

9

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

Immune reconstitution following T-cell depleted bone marrow transplantation: effect of age and posttransplant graft rejection prophylaxis

20 March 2024

17

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

Non-myeloablative transplants for malignant disease

20 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life

20 March 2024

34

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

Sequential analysis of early hematopoietic reconstitution following allogeneic bone marrow transplantation with fluorescence in situ hybridization (FISH)

20 March 2024

37

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00201-7

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference